Partner Fund Management »

Intra Cellular Therapies shares owned by Partner Fund Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.4M 41k 83.52
2024-09-30 $5.7M 77k 73.17
2024-06-30 $12M 170k 68.49
2024-03-31 $6.8M 99k 69.20

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Tenet Healthcare Corp Com New (THC)
Spdr Series Trust S&p Biotech Call Option (XBI)
Axsome Therapeutics (AXSM)
McKesson Corporation (MCK)
Penumbra (PEN)
United Therapeutics Corporation (UTHR)
Intuitive Surgical Com New (ISRG)
Edwards Lifesciences (EW)
Humana (HUM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Hca Holdings (HCA)
CVS Caremark Corporation (CVS)
AmerisourceBergen (COR)
Outset Med Com New (OM)

View all positions for Partner Fund Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies